amikacin has been researched along with Non-alcoholic Fatty Liver Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, L; Duan, M; Feng, Z; Sun, G; Tai, L; Wang, P; Wang, Q; Xu, X; Yuan, H; Zhang, S | 1 |
| Abou-Samra, M; Brichard, SM; Davis-López de Carrizosa, MA; Dubuisson, N; Gillard, J; Leclercq, IA; Nachit, M; Noel, L; Selvais, CM; Versele, R | 1 |
| Barbalho, SM; Fornari Laurindo, L; Méndez-Sánchez, N | 1 |
| Adjaye, J; Beller, M; Bohndorf, M; Czekelius, C; Fiszl, AR; Graffmann, N; Martins, S; Ncube, A; Reuther, P; Wruck, W | 1 |
1 review(s) available for amikacin and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review.
Topics: Adiponectin; Humans; Non-alcoholic Fatty Liver Disease; Receptors, Adiponectin | 2023 |
3 other study(ies) available for amikacin and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Discovery of novel AdipoRon analogues as potent anti-inflammatory agents against nonalcoholic steatohepatitis.
Topics: Animals; Anti-Inflammatory Agents; Inflammation; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Piperidines | 2022 |
AdipoRon enhances healthspan in middle-aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers.
Topics: Animals; Insulin Resistance; Lipids; Mice; Mice, Obese; Muscle, Skeletal; Non-alcoholic Fatty Liver Disease; Obesity; X-Ray Microtomography | 2023 |
A stem cell based
Topics: Adaptation, Biological; Adiponectin; Biomarkers; Cell Differentiation; Cells, Cultured; Diet, High-Fat; Energy Metabolism; Gene Expression Regulation; Gluconeogenesis; Hepatocytes; Humans; Induced Pluripotent Stem Cells; Lipid Metabolism; Non-alcoholic Fatty Liver Disease; Piperidines; Signal Transduction; Stem Cells | 2021 |